drugset / Trial / NCT03794076
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Phase 1/2
Recruiting
160 enrolled
Vishwajit Nimgaonkar, MD PhD
Stanley Medical Research Institute · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2028-01
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cromolyn | Small molecule | 5.2 mg | Intranasal |